<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37491461</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5578</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Molecular psychiatry</Title><ISOAbbreviation>Mol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update.</ArticleTitle><Pagination><StartPage>4056</StartPage><EndPage>4069</EndPage><MedlinePgn>4056-4069</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41380-023-02171-3</ELocationID><Abstract><AbstractText>The increasing number of coronavirus disease 2019 (COVID-19) infections have highlighted the long-term consequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection called long COVID. Although the concept and definition of long COVID are described differently across countries and institutions, there is general agreement that it affects multiple systems, including the immune, respiratory, cardiovascular, gastrointestinal, neuropsychological, musculoskeletal, and other systems. This review aims to provide a synthesis of published epidemiology, symptoms, and risk factors of long COVID. We also summarize potential pathophysiological mechanisms and biomarkers for precise prevention, early diagnosis, and accurate treatment of long COVID. Furthermore, we suggest evidence-based guidelines for the comprehensive evaluation and management of long COVID, involving treatment, health systems, health finance, public attitudes, and international cooperation, which is proposed to improve the treatment strategies, preventive measures, and public health policy making of long COVID.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Sizhen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yimiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scholl of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scholl of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoxing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yongbo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Peking-Tsinghua Center for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pain Medicine Center, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shuilin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scholl of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Shuyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scholl of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Yimiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking-Tsinghua Center for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhibo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Kai</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3498-8163</Identifier><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-5866-6230</Identifier><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Le</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4750-3492</Identifier><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravindran</LastName><ForeName>Arun V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosten</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1505-555X</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6567-8160</Identifier><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Yanping</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1881-0939</Identifier><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China. baoyp@bjmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scholl of Public Health, Peking University, Beijing, China. baoyp@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0742-9072</Identifier><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China. linlu@bjmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China. linlu@bjmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking-Tsinghua Center for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China. linlu@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Psychiatry</MedlineTA><NlmUniqueID>9607835</NlmUniqueID><ISSNLinking>1359-4184</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>26</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>23</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37491461</ArticleId><ArticleId IdType="doi">10.1038/s41380-023-02171-3</ArticleId><ArticleId IdType="pii">10.1038/s41380-023-02171-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl J Med. 2020;382:727&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">31978945</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">7092803</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO coronavirus (COVID-19) dashboard. 2023. https://covid19.who.int/ (Accessed 1 May 2023).</Citation></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371:m3862.</Citation><ArticleIdList><ArticleId IdType="pubmed">33097561</ArticleId><ArticleId IdType="doi">10.1136/bmj.m3862</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratiuk AL, Pillay TD, Kon OM, Lalvani A. A conceptual framework to accelerate the clinical impact of evolving research into long COVID. Lancet Infect Dis. 2021;21:756&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33894903</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(21)00136-5</ArticleId><ArticleId IdType="pmc">8062085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">36215063</ArticleId><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">9552043</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">33753937</ArticleId><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">8893149</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pubmed">34951953</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324:2251&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206133</ArticleId><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136.</Citation><ArticleIdList><ArticleId IdType="pubmed">33483331</ArticleId><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 .</Citation></Reference><Reference><Citation>Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10:863&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">35568052</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">9094732</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12&#x2009;months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Med. 2022;20:244.</Citation><ArticleIdList><ArticleId IdType="pubmed">35794549</ArticleId><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">9257572</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, Shikotra A, Singapuri A, Sereno M, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9:1275&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">34627560</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">8497028</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pubmed">34582441</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">8478214</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">35717982</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">9212672</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, Safarpour A, Lunz Trujillo K, Simonson MD, et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open. 2022;5:e2238804.</Citation><ArticleIdList><ArticleId IdType="pubmed">36301542</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">9614581</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226:1593&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">35429399</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N, Zhao YM, Yan W, Li C, Lu QD, Liu L et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry 2023;28:423&#x2013;33.</Citation></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13:3528.</Citation><ArticleIdList><ArticleId IdType="pubmed">35764621</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">9240035</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28:657&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">35124265</ArticleId><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">8812092</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, Ben Nasr M, D'Addio F, Loretelli C, Rossi A, Pastore I, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3:774&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">34035524</ArticleId><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">9931026</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Ortega M, Ponce-Rosas ER, Mu&#xf1;iz-Salinas DA, Rodr&#xed;guez-Mendoza O, N&#xe1;jera Ch&#xe1;vez P, S&#xe1;nchez-Pozos V, et al. Cognitive dysfunction, diabetes mellitus 2 and arterial hypertension: Sequelae up to one year of COVID-19. Travel Med Infect Dis. 2023;52:102553.</Citation><ArticleIdList><ArticleId IdType="pubmed">36805019</ArticleId><ArticleId IdType="doi">10.1016/j.tmaid.2023.102553</ArticleId><ArticleId IdType="pmc">9981335</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Yim JJ, Park J. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis. Respir Res. 2022;23:233.</Citation><ArticleIdList><ArticleId IdType="pubmed">36068582</ArticleId><ArticleId IdType="doi">10.1186/s12931-022-02163-x</ArticleId><ArticleId IdType="pmc">9446643</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered From coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1265&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">32730619</ArticleId><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">7385689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, Wing YK, Yu MW, Leung CM, Ma RC, Kong AP, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169:2142&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein L, Wong KK, Kallen AJ, Uyeki TM. Post-Ebola signs and symptoms in U.S. survivors. N. Engl J Med. 2015;373:2484&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26672870</ArticleId><ArticleId IdType="doi">10.1056/NEJMc1506576</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Tariq R, Jena A, Vesely EK, Singh S, Khanna S, et al. Gastrointestinal manifestations of long COVID: a systematic review and meta-analysis. Ther Adv Gastroenterol. 2022;15:17562848221118403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562848221118403</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou MI, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13:20406223221076890.</Citation><ArticleIdList><ArticleId IdType="pubmed">35198136</ArticleId><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">8859684</ArticleId></ArticleIdList></Reference><Reference><Citation>Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive impairment after COVID-19-a review on objective test data. Front Neurol. 2021;12:699582.</Citation><ArticleIdList><ArticleId IdType="pubmed">34393978</ArticleId><ArticleId IdType="doi">10.3389/fneur.2021.699582</ArticleId><ArticleId IdType="pmc">8357992</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">35255491</ArticleId><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">9046077</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021;4:e2036142.</Citation><ArticleIdList><ArticleId IdType="pubmed">33502487</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">7841464</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon DE, Gallman AE, Hruza GJ, Rosenbach M, Lipoff JB, Desai SR, et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021;21:313&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">33460566</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(20)30986-5</ArticleId><ArticleId IdType="pmc">7836995</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">33428867</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">7833295</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Long covid: hair loss and sexual dysfunction are among wider symptoms, study finds. BMJ. 2022;378:o1887.</Citation><ArticleIdList><ArticleId IdType="pubmed">35896202</ArticleId><ArticleId IdType="doi">10.1136/bmj.o1887</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Tracking SARS-CoV-2 variants. 2022. https://www.who.int/activities/tracking-SARS-CoV-2-variants .</Citation></Reference><Reference><Citation>Olaiz-Fernandez G, Vicuna de Anda FJ, Diaz-Ramirez JB, Fajardo Dolci GE, Bautista-Carbajal P, Angel-Ambrocio AH, et al. Effect of Omicron on the prevalence of COVID-19 in international travelers at the Mexico city international airport. December 16th, 2021 to January 31st, 2022. Travel Med Infect Dis. 2022;49:102361.</Citation><ArticleIdList><ArticleId IdType="pubmed">35640809</ArticleId><ArticleId IdType="doi">10.1016/j.tmaid.2022.102361</ArticleId><ArticleId IdType="pmc">9148423</ArticleId></ArticleIdList></Reference><Reference><Citation>Ra SH, Lim JS, Kim GU, Kim MJ, Jung J, Kim SH. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection. Thorax. 2021;76:61&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32963115</ArticleId><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralli M, Morrone A, Arcangeli A, Ercoli L. Asymptomatic patients as a source of transmission of COVID-19 in homeless shelters. Int J Infect Dis. 2021;103:243&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33321208</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2020.12.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiercehealthcare. New data offer glimpse at potential impact of emerging COVID variants. 2022. https://www.fiercehealthcare.com/payers/preliminary-data-point-challenges-new-covid-variants-present .</Citation></Reference><Reference><Citation>Cao Y, Jian F, Wang J, Yu Y, Song W, Yisimayi A et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature 2023;614:521&#x2013;29.</Citation></Reference><Reference><Citation>Qu P, Evans JP, Faraone JN, Zheng YM, Carlin C, Anghelina M et al. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe 2023;31:9&#x2013;17.e13.</Citation></Reference><Reference><Citation>Sheward DJ, Kim C, Fischbach J, Sato K, Muschiol S, Ehling RA, et al. Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies. Lancet Infect Dis. 2022;22:1538&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">36244347</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(22)00663-6</ArticleId><ArticleId IdType="pmc">9560757</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. Lancet Psychiatry. 2022;9:815&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">35987197</ArticleId><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">9385200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. How severe are omicron infections? Nature. 2021;600:577&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34934198</ArticleId><ArticleId IdType="doi">10.1038/d41586-021-03794-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui KPY, Ho JCW, Cheung MC, Ng KC, Ching RHH, Lai KL, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603:715&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">35104836</ArticleId><ArticleId IdType="doi">10.1038/s41586-022-04479-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics (ONS). Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/3november2022 .</Citation></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, Slopen N, Kubzansky LD, Koenen KC, et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA psychiatry. 2022;79:1081&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">36069885</ArticleId><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">9453634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayaaslan B, Eser F, Kalem AK, Kaya G, Kaplan B, Kacar D, et al. Post-COVID syndrome: a single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol. 2021;93:6566&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">34255355</ArticleId><ArticleId IdType="doi">10.1002/jmv.27198</ArticleId><ArticleId IdType="pmc">8426910</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33692530</ArticleId><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">7611399</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">35879616</ArticleId><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">9388369</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28:2398&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">36357676</ArticleId><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">9671810</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27:258&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">33031948</ArticleId><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27:1507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">34111579</ArticleId><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">8180450</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira JF, de &#xc1;vila RE, de Oliveira NR, da Cunha Severino Sampaio N, Botelho M, Gon&#xe7;alves FA, et al. Persistent symptoms, quality of life, and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil. Int J Infect Dis. 2022;122:1044&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">35908724</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2022.07.063</ArticleId><ArticleId IdType="pmc">9330427</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione L, Meli G, Poletti F, Rostagno R, Moglia R, Cantone M, et al. Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? QJM. 2022;114:865&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">34850210</ArticleId><ArticleId IdType="doi">10.1093/qjmed/hcab297</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28:611.e619&#x2013;611.e616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pr. 2021;75:e13746.</Citation></Reference><Reference><Citation>Galal I, Hussein AARM, Amin MT, Saad MM, Zayan HEE, Abdelsayed MZ, et al. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchol. 2021;15:10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-020-00049-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, Asgari Mehrabadi M, Abrahim HL, Dutt N, et al. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler looking for clarity in the haze of the pandemic. Clin Nurs Res. 2022;31:1390&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">36154716</ArticleId><ArticleId IdType="doi">10.1177/10547738221125632</ArticleId><ArticleId IdType="pmc">9510954</ArticleId></ArticleIdList></Reference><Reference><Citation>FAIR Health. A detailed study of patients with long-haul COVID. 2021. https://s3.amazonaws.com/media2.fairhealth.org/whitepaper/asset/A%20Detailed%20Study%20of%20Patients%20with%20Long-Haul%20COVID--An%20Analysis%20of%20Private%20Healthcare%20Claims--A%20FAIR%20Health%20White%20Paper.pdf .</Citation></Reference><Reference><Citation>Strahm C, Seneghini M, G&#xfc;sewell S, Egger T, Leal-Neto O, Brucher A, et al. Symptoms compatible with long coronavirus disease (COVID) in healthcare workers with and without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-results of a prospective multicenter cohort. Clin Infect Dis. 2022;75:e1011&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">35090015</ArticleId><ArticleId IdType="doi">10.1093/cid/ciac054</ArticleId><ArticleId IdType="pmc">9383387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13:5663.</Citation><ArticleIdList><ArticleId IdType="pubmed">36224173</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-33415-5</ArticleId><ArticleId IdType="pmc">9556711</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomogida K, Zhu S, Rubino F, Figueroa W, Balanji N, Holman E. Post-acute sequelae of SARS-CoV-2 infection among adults aged &#x2265;18 years - Long Beach, California, April 1-December 10, 2020. MMWR Morb Mortal Wkly Rep. 2021;70:1274&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">34529639</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7037a2</ArticleId><ArticleId IdType="pmc">8445372</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyraz B&#xc7;, Poyraz CA, Olgun Y, G&#xfc;rel &#xd6;, Alkan S, &#xd6;zdemir YE, et al. Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry Res. 2021;295:113604.</Citation><ArticleIdList><ArticleId IdType="pubmed">33296818</ArticleId><ArticleId IdType="doi">10.1016/j.psychres.2020.113604</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillay J, Rahman S, Guitard S, Wingert A, Hartling L. Risk factors and preventive interventions for post Covid-19 condition: systematic review. Emerg Microbes Infect. 2022;11:2762&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">36302216</ArticleId><ArticleId IdType="doi">10.1080/22221751.2022.2140612</ArticleId><ArticleId IdType="pmc">9665097</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B, Gornet M, Sims H, Kisanga E, Knight Z, Segars J. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its effect on gametogenesis and early pregnancy. Am J Reprod Immunol. 2020;84:e13351.</Citation><ArticleIdList><ArticleId IdType="pubmed">32969123</ArticleId><ArticleId IdType="doi">10.1111/aji.13351</ArticleId><ArticleId IdType="pmc">7537037</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20:442&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32528136</ArticleId><ArticleId IdType="doi">10.1038/s41577-020-0348-8</ArticleId><ArticleId IdType="pmc">7288618</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Shi L, Jiang Z, Zeng N, Mei H, Lu Y et al. The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China. Mol Psychiatry. 2023;28:1793&#x2013;1801.</Citation></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022;59:2101341.</Citation></Reference><Reference><Citation>Yuan K, Gong YM, Liu L, Sun YK, Tian SS, Wang YJ, et al. Prevalence of posttraumatic stress disorder after infectious disease pandemics in the twenty-first century, including COVID-19: a meta-analysis and systematic review. Mol Psychiatry. 2021;26:4982&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33542468</ArticleId><ArticleId IdType="doi">10.1038/s41380-021-01036-x</ArticleId><ArticleId IdType="pmc">7861006</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott HR, Stevelink SAM, Gafoor R, Lamb D, Carr E, Bakolis I, et al. Prevalence of post-traumatic stress disorder and common mental disorders in health-care workers in England during the COVID-19 pandemic: a two-phase cross-sectional study. Lancet Psychiatry. 2023;10:40&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">36502817</ArticleId><ArticleId IdType="doi">10.1016/S2215-0366(22)00375-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Ourworldindata. Coronavirus (COVID-19) vaccinations. 2023. https://ourworldindata.org/covid-vaccinations .</Citation></Reference><Reference><Citation>Moore S, Hill EM, Dyson L, Tildesley MJ, Keeling MJ. Retrospectively modeling the effects of increased global vaccine sharing on the COVID-19 pandemic. Nat Med. 2022;28:2416&#x2013;23.</Citation></Reference><Reference><Citation>Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its management. Int J Biol Sci. 2022;18:4768&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">35874958</ArticleId><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">9305273</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">34480857</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">8409907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, King S, Pouwels KB, Glickman M, Nafilyan V, et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum Infect Dis. 2022;9:ofac464.</Citation><ArticleIdList><ArticleId IdType="pubmed">36168555</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">9494414</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328:676&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">35796131</ArticleId><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">9250078</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Liu J, Liu M Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health 2022;19:12422.</Citation></Reference><Reference><Citation>Taghioff SM, Slavin BR, Holton T, Singh D. Examining the potential benefits of the influenza vaccine against SARS-CoV-2: a retrospective cohort analysis of 74,754 patients. PloS One. 2021;16:e0255541.</Citation><ArticleIdList><ArticleId IdType="pubmed">34343191</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0255541</ArticleId><ArticleId IdType="pmc">8330918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest. 2022;132:e161167.</Citation></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54:1473&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">35594336</ArticleId><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">9132392</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Morrone MC, Patrono C, Santoro MG, Schiaffino S, Remuzzi G, et al. Long Covid: where we stand and challenges ahead. Cell Death Differ. 2022;29:1891&#x2013;1900.</Citation><ArticleIdList><ArticleId IdType="pubmed">36071155</ArticleId><ArticleId IdType="pmc">9449925</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A .The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;96.</Citation></Reference><Reference><Citation>Bakar Siddiq M, Rasker J. COVID-19, long COVID, and psychosomatic manifestations: a possible burden on existing rheumatology facilities. Heart Mind. 2022;6:195&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/hm.hm_63_21</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;63.</Citation></Reference><Reference><Citation>Li Q, Zheng XS, Shen XR, Si HR, Wang X, Wang Q, et al. Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19. Emerg Microbes Infect. 2020;9:2571&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33196399</ArticleId><ArticleId IdType="doi">10.1080/22221751.2020.1852058</ArticleId><ArticleId IdType="pmc">7734137</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Yuan K, Wang Z, Liu WJ, Lu ZA, Liu L, et al. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions. Transl Psychiatry. 2021;11:499.</Citation><ArticleIdList><ArticleId IdType="pubmed">34593760</ArticleId><ArticleId IdType="doi">10.1038/s41398-021-01629-8</ArticleId><ArticleId IdType="pmc">8482959</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. 2021;13:eabf8396.</Citation></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122.</Citation><ArticleIdList><ArticleId IdType="pubmed">35271343</ArticleId><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen JI. Epstein-Barr virus infection. N. Engl J Med. 2000;343:481&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">10944566</ArticleId><ArticleId IdType="doi">10.1056/NEJM200008173430707</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to epstein-barr virus reactivation. Pathogens. 2021;10:763.</Citation></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e820.</Citation><ArticleIdList><ArticleId IdType="pubmed">35216672</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">8786632</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">33461210</ArticleId><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">8221082</ArticleId></ArticleIdList></Reference><Reference><Citation>Theofilopoulos AN, Kono DH, Baccala R. The multiple pathways to autoimmunity. Nat Immunol. 2017;18:716&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">28632714</ArticleId><ArticleId IdType="doi">10.1038/ni.3731</ArticleId><ArticleId IdType="pmc">5791156</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, Furst J, Schulze-Rothe S, Wallukat A, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100.</Citation><ArticleIdList><ArticleId IdType="pubmed">33880442</ArticleId><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">8049853</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR et al. Distinguishing features of long COVID identified through immune profiling. medRxiv 2022;2022.08.09.22278592.</Citation></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12:698169.</Citation><ArticleIdList><ArticleId IdType="pubmed">34248921</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">8260991</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Yan W, Lu T, Han Y, Lu L. Longitudinal abnormalities in brain structure in COVID-19 patients. Neurosci Bull. 2022;38:1608&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">35794292</ArticleId><ArticleId IdType="doi">10.1007/s12264-022-00913-x</ArticleId><ArticleId IdType="pmc">9261203</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T, Wu J, Chen T, Li J, Yan S, Zhou Y et al. Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations. JCI Insight. 2022;7:e155827.</Citation></Reference><Reference><Citation>Cecchetti G, Agosta F, Canu E, Basaia S, Barbieri A, Cardamone R, et al. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol. 2022;269:3400&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">35249144</ArticleId><ArticleId IdType="doi">10.1007/s00415-022-11047-5</ArticleId><ArticleId IdType="pmc">8898558</ArticleId></ArticleIdList></Reference><Reference><Citation>Du YY, Zhao W, Zhou XL, Zeng M, Yang DH, Xie XZ, et al. Survivors of COVID-19 exhibit altered amplitudes of low frequency fluctuation in the brain: a resting-state functional magnetic resonance imaging study at 1-year follow-up. Neural Regen Res. 2022;17:1576&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">34916443</ArticleId><ArticleId IdType="doi">10.4103/1673-5374.327361</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovasc Diabetol. 2022;21:148.</Citation><ArticleIdList><ArticleId IdType="pubmed">35933347</ArticleId><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">9356426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A, Vlok M, Turner S, Venter C, Laubscher GJ, Kell DB, et al. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabetol. 2022;21:190.</Citation><ArticleIdList><ArticleId IdType="pubmed">36131342</ArticleId><ArticleId IdType="doi">10.1186/s12933-022-01623-4</ArticleId><ArticleId IdType="pmc">9491257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J. 2022;479:537&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">35195253</ArticleId><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HY, Ning MX, Chen DK, Ma WT. Interactions between the gut microbiota and the host innate immune response against pathogens. Front Immunol. 2019;10:607.</Citation><ArticleIdList><ArticleId IdType="pubmed">30984184</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2019.00607</ArticleId><ArticleId IdType="pmc">6449424</ArticleId></ArticleIdList></Reference><Reference><Citation>Alharbi KS, Singh Y, Hassan Almalki W, Rawat S, Afzal O, Alfawaz Altamimi AS, et al. Gut microbiota disruption in COVID-19 or post-COVID illness association with severity biomarkers: a possible role of pre / pro-biotics in manipulating microflora. Chem Biol Interact. 2022;358:109898.</Citation><ArticleIdList><ArticleId IdType="pubmed">35331679</ArticleId><ArticleId IdType="doi">10.1016/j.cbi.2022.109898</ArticleId><ArticleId IdType="pmc">8934739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944&#x2013;55.e948.</Citation><ArticleIdList><ArticleId IdType="pubmed">32442562</ArticleId><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestad B, Ueland T, Lerum TV, Dahl TB, Holm K, Barratt-Due A, et al. Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations. J Intern Med. 2022;291:801&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">35212063</ArticleId><ArticleId IdType="doi">10.1111/joim.13458</ArticleId><ArticleId IdType="pmc">9115297</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33172844</ArticleId><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizjak DA, Stangl M, B&#xf6;rner N, B&#xf6;sch F, Durner J, Drunin G, et al. Kynurenine serves as useful biomarker in acute, long- and post-COVID-19 diagnostics. Front Immunol. 2022;13:1004545.</Citation><ArticleIdList><ArticleId IdType="pubmed">36211365</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1004545</ArticleId><ArticleId IdType="pmc">9537769</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Schank M, Wang L, Dang X, Cao D, Khanal S, et al. Plasma biomarkers for systemic inflammation in COVID-19 survivors. Proteom Clin Appl. 2022;16:e2200031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.202200031</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Xiang X, Ren H, Xu L, Zhao L, Chen X, et al. Serum amyloid A is a biomarker of severe coronavirus disease and poor prognosis. J Infect. 2020;80:646&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">32277967</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2020.03.035</ArticleId><ArticleId IdType="pmc">7141628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua-Huy T, G&#xfc;nther S, Lorut C, Subileau M, Aubourg F, Morbieu C et al. Distal lung inflammation assessed by alveolar concentration of nitric oxide Is an individualised biomarker of severe COVID-19 pneumonia. J Pers Med 2022;12:1631.</Citation></Reference><Reference><Citation>Yang Z, Wu D, Lu S, Qiu Y, Hua Z, Tan F, et al. Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients. Proc Natl Acad Sci USA. 2022;119:e2117089119.</Citation><ArticleIdList><ArticleId IdType="pubmed">35943976</ArticleId><ArticleId IdType="doi">10.1073/pnas.2117089119</ArticleId><ArticleId IdType="pmc">9407385</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Ryan-Murua P, Rodr&#xed;guez-Jim&#xe9;nez J, Palacios-Ce&#xf1;a M, Arendt-Nielsen L, Torres-Macho J. Serological biomarkers at hospital admission are not related to long-term post-COVID fatigue and dyspnea in COVID-19 survivors. Respiration. 2022;101:658&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">35381597</ArticleId><ArticleId IdType="doi">10.1159/000524042</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabanoglu C, Inanc IH, Polat E, Peker SA. Long-term predictive value of cardiac biomarkers in patients with COVID-19 infection. Eur Rev Med Pharm Sci. 2022;26:6396&#x2013;403.</Citation></Reference><Reference><Citation>Motloch LJ, Jirak P, Gareeva D, Davtyan P, Gumerov R, Lakman I, et al. Cardiovascular biomarkers for prediction of in-hospital and 1-year post-discharge mortality in patients with COVID-19 pneumonia. Front Med (Lausanne). 2022;9:906665.</Citation><ArticleIdList><ArticleId IdType="pubmed">35836945</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.906665</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, Go&#xdf;ling A, Adam G, Aepfelbacher M, Behrendt CA, Cavus E, et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme. Eur Heart J. 2022;43:1124&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">34999762</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehab914</ArticleId><ArticleId IdType="pmc">8755397</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhre PL, Heck SL, Skranes JB, Prebensen C, Jonassen CM, Berge T, et al. Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity. Am Heart J. 2021;242:61&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">34400140</ArticleId><ArticleId IdType="doi">10.1016/j.ahj.2021.08.001</ArticleId><ArticleId IdType="pmc">8363180</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong M, Yan X, Jiang Y, Jin Z, Zhu S, Zou L, et al. Endothelial biomarkers in patients recovered from COVID-19 one year after hospital discharge: a cross-sectional study. Mediterr J Hematol Infect Dis. 2022;14:e2022033.</Citation><ArticleIdList><ArticleId IdType="pubmed">35615329</ArticleId><ArticleId IdType="doi">10.4084/MJHID.2022.033</ArticleId><ArticleId IdType="pmc">9084173</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Martin S, Shchendrygina A, Hoffmann J, Ka MM, Giokoglu E, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med. 2022;28:2117&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">36064600</ArticleId><ArticleId IdType="doi">10.1038/s41591-022-02000-0</ArticleId><ArticleId IdType="pmc">9556300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wais T, Hasan M, Rai V, Agrawal DK. Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics. Expert Rev Clin Immunol. 2022;18:947&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">35868344</ArticleId><ArticleId IdType="doi">10.1080/1744666X.2022.2105697</ArticleId><ArticleId IdType="pmc">9388545</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Grimshaw M, Chirino-P&#xe9;rez A, Flores-Silva FD, Vald&#xe9;s-Ferrer SI, Vargas-Mart&#xed;nez M, Jim&#xe9;nez-&#xc1;vila AI, et al. Critical role of acute hypoxemia on the cognitive impairment after severe COVID-19 pneumonia: a multivariate causality model analysis. Neurol Sci. 2022;43:2217&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">35022935</ArticleId><ArticleId IdType="doi">10.1007/s10072-021-05798-8</ArticleId><ArticleId IdType="pmc">8754526</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez M, Trent E, Goncalves BS, Pereira DG, Puri R, Frazier NA, et al. Cognitive dysfunction associated with COVID-19: prognostic role of circulating biomarkers and microRNAs. Front Aging Neurosci. 2022;14:1020092.</Citation><ArticleIdList><ArticleId IdType="pubmed">36268187</ArticleId><ArticleId IdType="doi">10.3389/fnagi.2022.1020092</ArticleId><ArticleId IdType="pmc">9577202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N, Simr&#xe9;n J, Ed&#xe9;n A, Andersson LM, Nilsson S, Ashton NJ, et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 2021;70:103512.</Citation><ArticleIdList><ArticleId IdType="pubmed">34333238</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2021.103512</ArticleId><ArticleId IdType="pmc">8320425</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL et al. Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells. 2021;10:386.</Citation></Reference><Reference><Citation>Guasp M, Mu&#xf1;oz-S&#xe1;nchez G, Mart&#xed;nez-Hern&#xe1;ndez E, Santana D, Carbayo &#xc1;, Naranjo L, et al. CSF biomarkers in COVID-19 associated encephalopathy and encephalitis predict long-term outcome. Front Immunol. 2022;13:866153.</Citation><ArticleIdList><ArticleId IdType="pubmed">35479062</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.866153</ArticleId><ArticleId IdType="pmc">9035899</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, et al. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat Neurosci. 2021;24:368&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">33328624</ArticleId><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32240762</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">7146689</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hadrawi DS, Al-Rubaye HT, Almulla AF, Al-Hakeim HK, Maes M Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precision nomothetic approach. Acta Neuropsychiatr. 2022;35:76-87.</Citation></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">33639239</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">7903920</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson G. Research priorities for long covid: refined through an international multi-stakeholder forum. BMC Med. 2021;19:84.</Citation><ArticleIdList><ArticleId IdType="pubmed">33785027</ArticleId><ArticleId IdType="doi">10.1186/s12916-021-01947-0</ArticleId><ArticleId IdType="pmc">8009733</ArticleId></ArticleIdList></Reference><Reference><Citation>National institute for health and care excellence: clinical guidelines. COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Excellence (NICE) Copyright &#xa9; NICE 2020: London, 2020.</Citation></Reference><Reference><Citation>Sachs JD, Karim SSA, Aknin L, Allen J, Brosb&#xf8;l K, Colombo F et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. 2022;400:1224&#x2013;80.</Citation></Reference><Reference><Citation>Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long covid-an update for primary care. BMJ. 2022;378:e072117.</Citation><ArticleIdList><ArticleId IdType="pubmed">36137612</ArticleId><ArticleId IdType="doi">10.1136/bmj-2022-072117</ArticleId></ArticleIdList></Reference><Reference><Citation>Joli J, Buck P, Zipfel S, Stengel A. Post-COVID-19 fatigue: a systematic review. Front Psychiatry. 2022;13:947973.</Citation><ArticleIdList><ArticleId IdType="pubmed">36032234</ArticleId><ArticleId IdType="doi">10.3389/fpsyt.2022.947973</ArticleId><ArticleId IdType="pmc">9403611</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson P, Wang G, McGarvey L, Vertigan AE, Altman KW, Birring SS, et al. Treatment of unexplained chronic cough: CHEST guideline and expert panel report. Chest. 2016;149:27&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">26426314</ArticleId><ArticleId IdType="doi">10.1378/chest.15-1496</ArticleId><ArticleId IdType="pmc">5831652</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WJ, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB, et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021;9:533&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">33857435</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(21)00125-9</ArticleId><ArticleId IdType="pmc">8041436</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamberlain Mitchell SA, Garrod R, Clark L, Douiri A, Parker SM, Ellis J, et al. Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial. Thorax. 2017;72:129&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">27682331</ArticleId><ArticleId IdType="doi">10.1136/thoraxjnl-2016-208843</ArticleId></ArticleIdList></Reference><Reference><Citation>National institute for health and care excellence. Atrial fibrillation: diagnosis and management NICE guideline. National Institute for Health and Care Excellence (NICE) Copyright &#xa9; NICE 2020: London, 2020.</Citation></Reference><Reference><Citation>National institute for health and care excellence. Acute coronary syndromes NICE guideline. National Institute for Health and Care Excellence (NICE) Copyright &#xa9; NICE 2020.: London, 2020.</Citation></Reference><Reference><Citation>Parker AM, Brigham E, Connolly B, McPeake J, Agranovich AV, Kenes MT, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9:1328&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">34678213</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(21)00385-4</ArticleId><ArticleId IdType="pmc">8525917</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy J, Valli&#xe8;res F, Bentall RP, Shevlin M, McBride O, Hartman TK, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021;12:29.</Citation><ArticleIdList><ArticleId IdType="pubmed">33397962</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-20226-9</ArticleId><ArticleId IdType="pmc">7782692</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. COVID-19 vaccines. 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines .</Citation></Reference><Reference><Citation>Zheng YB, Sun J, Liu L, Zhao YM, Yan W, Yuan K, et al. COVID-19 vaccine-related psychological stress among general public in China. Front Psychiatry. 2021;12:774504.</Citation><ArticleIdList><ArticleId IdType="pubmed">34950070</ArticleId><ArticleId IdType="doi">10.3389/fpsyt.2021.774504</ArticleId><ArticleId IdType="pmc">8689133</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Ni SY, Yan W, Lu QD, Zhao YM, Xu YY, et al. Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: a systematic review, meta-analysis and call for action. EClinicalMedicine. 2021;40:101111.</Citation><ArticleIdList><ArticleId IdType="pubmed">34514362</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2021.101111</ArticleId><ArticleId IdType="pmc">8424080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng YB, Shi L, Lu ZA, Que JY, Yuan K, Huang XL, et al. Mental health status of late-middle-aged adults in China during the coronavirus disease 2019 pandemic. Front Public Health. 2021;9:643988.</Citation><ArticleIdList><ArticleId IdType="pubmed">34123986</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2021.643988</ArticleId><ArticleId IdType="pmc">8187778</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y, Liu X, Zheng Y, Mei H, Que J, Yuan K, et al. COVID-19 induced economic slowdown and mental health issues. Front Psychol. 2022;13:777350.</Citation><ArticleIdList><ArticleId IdType="pubmed">35310204</ArticleId><ArticleId IdType="doi">10.3389/fpsyg.2022.777350</ArticleId><ArticleId IdType="pmc">8931846</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne EA. Understanding long covid: nosology, social attitudes and stigma. Brain Behav Immun. 2022;99:17&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">34563621</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2021.09.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan K, Huang XL, Yan W, Zhang YX, Gong YM, Su SZ, et al. A systematic review and meta-analysis on the prevalence of stigma in infectious diseases, including COVID-19: a call to action. Mol Psychiatry. 2022;27:19&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">34580416</ArticleId><ArticleId IdType="doi">10.1038/s41380-021-01295-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Liu L, Sun J, Yan W, Yuan K, Zheng YB et al. Public willingness and determinants of COVID-19 vaccination at the initial stage of mass vaccination in China. Vaccines (Basel). 2021;9:1172.</Citation></Reference><Reference><Citation>Li H, Yuan K, Sun YK, Zheng YB, Xu YY, Su SZ, et al. Efficacy and practice of facemask use in general population: a systematic review and meta-analysis. Transl Psychiatry. 2022;12:49.</Citation><ArticleIdList><ArticleId IdType="pubmed">35105851</ArticleId><ArticleId IdType="doi">10.1038/s41398-022-01814-3</ArticleId><ArticleId IdType="pmc">8804079</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27:225&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33082575</ArticleId><ArticleId IdType="doi">10.1038/s41591-020-1124-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y, Liu X, Su S, Bao Y, Kosten TR, Lu L. Addressing mental health issues amid the COVID-19 pandemic: a wake-up call. Sci Bull (Beijing). 2022;67:2259&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">36311542</ArticleId><ArticleId IdType="doi">10.1016/j.scib.2022.10.022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>